SUpport From PEeRs to Expand Access Study - Community
SUPERA: Supporting Peer Interactions to Expand Access to Digital Cognitive Behavioral Therapy for Spanish-speaking in the San Francisco Mission Community
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years to 100 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests SilverCloud, an online program in Spanish that helps people change thoughts and actions linked to depression or anxiety. It is for Latino adults in the Mission community who prefer care in Spanish. The study will compare using the program alone with using it with support.
Investigators will evaluate the implementation of an evidence-based, Spanish-language, digital, cognitive-behavioral therapy (dCBT) intervention (SilverCloud) in the Mission community for Latino patients with depression and/or anxiety. 213 participants will be enrolled in a one-armed trial comparing self-guided vs. supported dCBT (SilverCloud).
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Age 18 or older.
- A score of 10 or higher on the PHQ-9 depression survey, or 8 or higher on the GAD-7 anxiety survey.
- Have internet access through a smartphone or home broadband.
- Have basic technology skills or be willing to take a short training.
- Prefer to receive medical care in Spanish.
- Not currently getting talk therapy.
- If taking medicine for depression, have been on the same dose for at least 6 weeks, with no plans to change it.
Who can't join
- Currently getting talk therapy. People may be referred to therapy after joining the study.
- Problems with seeing, hearing, speaking, moving, or reading that would prevent completing study tasks.
- A diagnosis of a psychotic disorder (trouble knowing what is real), bipolar disorder (extreme mood changes), dissociative disorder (feeling disconnected from yourself or your surroundings), or substance use disorder (harmful use of alcohol or drugs).
- Severe suicide risk, with thoughts, a plan, and intent to act. These people will be referred for more intensive care.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: 1. PHQ-9 ≥ 10 or GAD-7 ≥ 8 2. Has access to the Internet via smartphone and/or broadband at home, and basic level of technological literacy or willingness to undergo a brief technology use training 3. ≥18 years of age 4. Preference for receiving medical care in Spanish 5. Not in concurrent psychotherapy 6. If currently taking an antidepressant medication, patient must have been on a stable dose for at least 6 weeks, and have no plans to change the dose. We will permit patients on antidepressants to enter the study, as this will increase generalizability. Antidepressant status will be monitored at each assessment to control for those effects, if necessary. Exclusion Criteria: 1. Currently receiving psychotherapy, as this treatment will be offered as a frontline treatment for depression and anxiety, however, patients are allowed to be referred to treatment while participating in this study and initiation of treatment will be monitored and considered in analyses 2. Visual, hearing, voice, or motor impairment or illiteracy that would prevent completion of study procedures 3. Diagnosis of a psychotic disorder, bipolar disorder, dissociative disorder, or substance use disorder 4. Severe suicidality (as assessed by expressing suicidal ideation, plan, and intent). Although procedures with back-up plans are in place for patients who develop suicidality (see Human Subjects Section), patients assessed with severe suicidality will be referred to more-intensive treatment resources.
Study sites (1)
CA
- Zuckerberg San Francisco General · San Francisco, CA 94110Aguilera · Study contact · 650-784-5939 · aguila@berkeley.eduMore trials in San Francisco